This ETF offers -3x daily leveraged exposure to a benchmark that includes companies engaged in the manufacture of health care products and materials and those responsible for providing health-related services. Given the sector-specific focus and the leveraged exposure, SICK doesn't make sense as a component of a long-term, buy-and-hold portfolios; this product is appropriate only for risk-tolerant investors looking to express a very bearish outlook on the U.S. health care sector over a relatively short period of time. Investors looking to establish a non-leveraged position in health care stocks have multiple choices in the Health & Biotech Equities ETFdb Category, including XLV (which is linked to the same index as this product but is unleveraged). It is important for investors considering this leveraged ETF to understand the impact that the daily reset feature has on the risk/return profile. SICK is designed to offer -3x leveraged exposure to the underlying index over the course of a single trading session only; holding this leveraged ETF for longer or shorter than this time period may result in returns that vary from the daily target multiple--sometimes by a wide margin. SICK can still be used effectively as part of longer-term strategy to profit from a decline in the health care sector; investors must simply understand the nuances of compounding returns in a daily reset product, and be willing to monitor performance and exposure and rebalance as needed. Investors looking to make a leveraged bet on bullish performance from health care stocks have CURE available, while those seeking 2x exposure may prefer RXL (long) or RXD (short).
The adjacent table gives investors an individual Realtime Rating for SICK on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Leveraged Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.View the Category Report
The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its ETFdb.com Category.
This section compares how balanced and deep this ETF is relative to the peer group ETFdb.com Category.
This ETF is not currently available for commission free trading on any platforms.
There are 0 other ETFs in the Leveraged Equities ETFdb.com Category that are also eligible for commission free trading:
This section shows how this ETF has performed relative to its peer group ETFdb.com Category.
The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.
The following chart also includes the option to compare the performance of SICK relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.
This section shows how the volatility of this ETF compares to the peer group ETFdb.com Category.
Source: LSEG Information Services (US), Inc. (“LSEG”) © LSEG 2016. All rights in the XTF data, ratings and / or underlying data contained in this communication (“the XTF information”) vest in LSEG and/or its licensors. Neither LSEG nor its licensors accept any liability arising out of the use of, reliance on or any errors or omissions in the XTF information. No further distribution of the XTF information is permitted without LSEG’s express written consent. LSEG does not promote, sponsor or endorse the content of this communication.